Literature DB >> 32047761

Testing microsatellite instability in solid tumors: the ideal versus what is real.

Virgilio Souza E Silva1, Louise De Brot2, Rachel P Riechelmann1.   

Abstract

Entities:  

Year:  2019        PMID： 32047761      PMCID： PMC7011591          DOI： 10.21037/atm.2019.09.124

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  23 in total

1.  Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.

Authors:  Noralane M Lindor; Lawrence J Burgart; Olga Leontovich; Richard M Goldberg; Julie M Cunningham; Daniel J Sargent; Catherine Walsh-Vockley; Gloria M Petersen; Michael D Walsh; Barbara A Leggett; Joanne P Young; Melissa A Barker; Jeremy R Jass; John Hopper; Steve Gallinger; Bharati Bapat; Mark Redston; Stephen N Thibodeau
Journal:  J Clin Oncol       Date:  2002-02-15       Impact factor: 44.544

2.  Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer.

Authors:  T Debniak; G Kurzawski; B Gorski; J Kladny; W Domagala; J Lubinski
Journal:  Eur J Cancer       Date:  2000-01       Impact factor: 9.162

3.  Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors.

Authors:  Olivier Buhard; Francesca Cattaneo; Yick Fu Wong; So Fan Yim; Eitan Friedman; Jean-François Flejou; Alex Duval; Richard Hamelin
Journal:  J Clin Oncol       Date:  2005-12-05       Impact factor: 44.544

4.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

Authors:  Dung T Le; Jennifer N Uram; Hao Wang; Bjarne R Bartlett; Holly Kemberling; Aleksandra D Eyring; Andrew D Skora; Brandon S Luber; Nilofer S Azad; Dan Laheru; Barbara Biedrzycki; Ross C Donehower; Atif Zaheer; George A Fisher; Todd S Crocenzi; James J Lee; Steven M Duffy; Richard M Goldberg; Albert de la Chapelle; Minori Koshiji; Feriyl Bhaijee; Thomas Huebner; Ralph H Hruban; Laura D Wood; Nathan Cuka; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; Shibin Zhou; Toby C Cornish; Janis M Taube; Robert A Anders; James R Eshleman; Bert Vogelstein; Luis A Diaz
Journal:  N Engl J Med       Date:  2015-05-30       Impact factor: 91.245

5.  ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.

Authors:  C Luchini; F Bibeau; M J L Ligtenberg; N Singh; A Nottegar; T Bosse; R Miller; N Riaz; J-Y Douillard; F Andre; A Scarpa
Journal:  Ann Oncol       Date:  2019-08-01       Impact factor: 32.976

6.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

Review 7.  Microsatellite Instability as a Biomarker for PD-1 Blockade.

Authors:  Jonathan C Dudley; Ming-Tseh Lin; Dung T Le; James R Eshleman
Journal:  Clin Cancer Res       Date:  2016-02-15       Impact factor: 12.531

8.  Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing.

Authors:  Liying Zhang
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568

9.  Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.

Authors:  Zachary R Chalmers; Caitlin F Connelly; David Fabrizio; Laurie Gay; Siraj M Ali; Riley Ennis; Alexa Schrock; Brittany Campbell; Adam Shlien; Juliann Chmielecki; Franklin Huang; Yuting He; James Sun; Uri Tabori; Mark Kennedy; Daniel S Lieber; Steven Roels; Jared White; Geoffrey A Otto; Jeffrey S Ross; Levi Garraway; Vincent A Miller; Phillip J Stephens; Garrett M Frampton
Journal:  Genome Med       Date:  2017-04-19       Impact factor: 11.117

10.  Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status.

Authors:  Romain Cohen; Elisabeth Hain; Olivier Buhard; Agathe Guilloux; Armelle Bardier; Rachid Kaci; Philippe Bertheau; Florence Renaud; Frédéric Bibeau; Jean-François Fléjou; Thierry André; Magali Svrcek; Alex Duval
Journal:  JAMA Oncol       Date:  2019-04-01       Impact factor: 31.777
View more
  2 in total

1.  Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States.

Authors:  Sneha S Kelkar; Vimalanand S Prabhu; Jingchuan Zhang; Shelby Corman; Cynthia Macahilig; Nifasha Rusibamayila; Shardul Odak; Linda R Duska
Journal:  Gynecol Oncol Rep       Date:  2022-06-17

Review 2.  Immunotherapy in Metastatic Colorectal Cancer: Could the Latest Developments Hold the Key to Improving Patient Survival?

Authors:  Emmanouil Damilakis; Dimitrios Mavroudis; Maria Sfakianaki; John Souglakos
Journal:  Cancers (Basel)       Date:  2020-04-06       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.